X-ray study reveals long-sought insights into potential drug target
2 institutional releases
Published in Nature · View the paper (DOI)
Researchers discovered new structural details of an angiotensin II receptor called AT2, which could be a target for new medicines. The information uncovered could give drug developers a new path for compounds that combat pain and inflammation or promote tissue regeneration.